Day: November 10, 2020

Communiqué de presse Capgemini // Capgemini annonce son intention d’acquérir RXP Services, société de conseil et de services australienne experte en solutions digitales

Bonjour,Vous trouverez ci-après le communiqué de presse diffusé ce jour à 9h00 du matin, heure de Sydney.Bien cordialement,Florence LièvreGlobal PR Manager | Group Marketing & CommunicationsCapgemini Group | ParisTel.: +33 1 47 54 50 71Email : florence.lievre@capgemini.com_____________________Relations Media :Florence LièvreTél. : 01 47 54 50 71florence.lievre@capgemini.comRelations Investisseurs :Vincent BiraudTél. : 01 47 54 50 87vincent.biraud@capgemini.comCapgemini annonce son intention d’acquérir RXP Services, société de conseil et de services australienne experte en solutions digitalesCette acquisition renforcerait significativement la position de Capgemini en AustralieParis, le 10 novembre 2020 – Capgemini annonce la conclusion d’un accord (Scheme Implementation Deed)1 en vue d’acquérir la société australienne RXP Services...

Continue reading

Ashland reports preliminary financial results for fourth quarter of fiscal year 2020

Sales of $609 million, flat compared to the prior-year quarterNet income of $5 million, or $0.07 per diluted shareIncome from continuing operations was zeroAdjusted income from continuing operations excluding intangibles amortization expense of $76 million, or $1.25 per diluted shareAdjusted EBITDA of $154 millionCash flows provided by operating activities of $160 million; free cash flows of $116 millionWILMINGTON, Del., Nov. 10, 2020 (GLOBE NEWSWIRE) — Ashland Global Holdings Inc. (NYSE: ASH) today announced preliminary1 financial results for the fourth quarter of fiscal year 2020 which ended September 30, 2020. The global specialty materials company serves customers in a wide range of consumer and industrial markets.Ashland’s financial results during the quarter reflected both strong resiliency in demand and the positive impact...

Continue reading

BBQ Holdings, Inc. Reports Results for Third Quarter of Fiscal Year 2020

MINNEAPOLIS, Nov. 10, 2020 (GLOBE NEWSWIRE) — BBQ Holdings, Inc. (NASDAQ: BBQ) (the “Company”), an innovating global owner and operator of restaurants, today reported financial results for the third fiscal quarter ended September 27, 2020. Note: The third quarter results were affected by the COVID-19 pandemic as well as federal and state level mandates requiring restaurants to limit or eliminate in-store dining.Third Quarter 2020 Highlights:Net income of $328,000, driven in part by a gain on a renegotiated leased asset of $630,000.Adjusted EBITDA, a non-GAAP measure was $2.0 million which includes a $1.1 million COVID-related expense addback.Company-owned Famous Dave’s third quarter same store net sales decreased 4.6% compared to third quarter 2019.Franchise-operated same store net sales decreased 10.0%.Granite City third quarter...

Continue reading

Ascot Resources Announces Financial Results for the Nine Months Ended September 30, 2020

VANCOUVER, British Columbia, Nov. 10, 2020 (GLOBE NEWSWIRE) — Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) announces the Company’s unaudited financial results for the nine months ended September 30, 2020. For details of the unaudited condensed interim consolidated financial statements and Management’s Discussion and Analysis for the nine months ended September 30, 2020, please see the Company’s filings on SEDAR (www.sedar.com).All amounts herein are reported in $000s of Canadian dollars (“C$”) unless otherwise specified.Q3 2020 AND RECENT HIGHLIGHTSIn July and August of 2020, the Company reported high gold grades from ten drill holes (2,820 metres) of the 2020 season. The drill site is strategically located at Premier West, potentially adding to existing resources outlined in the feasibility;On...

Continue reading

Profound Medical to Participate in November Virtual Investor Healthcare Conferences

TORONTO, Nov. 10, 2020 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, announced today that management will participate in three investor conferences in November.Jefferies Virtual London Healthcare Conference: Profound is scheduled to participate in a fireside chat on Tuesday, November 17, 2020 at 12:00 p.m. ET (5:00 p.m. GMT). The fireside chat will be broadcast live and archived on the Company’s website at www.profoundmedical.com under “Webcasts” in the Investors section.Canaccord Genuity Virtual MedTech & Diagnostics Forum:...

Continue reading

MeiraGTx to Present at the Barclays Gene Editing & Gene Therapy Summit

LONDON and NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., president and chief executive officer, will present at the Barclays Gene Editing & Gene Therapy Summit on Monday, November 16, 2020 at 1:30 p.m. ET.A live webcast of the presentation will be available on the Investors page of the Company’s website at www.investors.meiragtx.com. A replay of the webcast will be available for approximately 30 days following the presentation.About MeiraGTxMeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in viral vector design and...

Continue reading

Turning Point Therapeutics to Participate in Jefferies Virtual London Healthcare Conference

SAN DIEGO, Nov. 10, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced that President and CEO Athena Countouriotis, M.D., will present a company overview at the Jefferies Virtual London Healthcare Conference on Nov. 18.Dr. Countouriotis’ session is scheduled to begin at 12:35 p.m. ET and will be accessible via webcast through the Investors page of www.tptherapeutics.com.About Turning Point Therapeutics Inc.Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of internally discovered investigational drugs designed to address key limitations of existing cancer therapies. The company’s lead drug candidate, repotrectinib, is a next-generation kinase inhibitor...

Continue reading

Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference

EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer is scheduled to present at the Jefferies Virtual London Healthcare Conference.Details of the presentation are as follows:A live webcast of the fireside chat will be available under the “For Investors” section of the Antares Pharma website at www.antarespharma.com.About Antares PharmaAntares Pharma, Inc. is a pharmaceutical technology company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various...

Continue reading

Infinera to Present at the Needham Virtual Security, Networking, and Communications Conference

SUNNYVALE, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Infinera Corporation (NASDAQ: INFN) announced today that Tom Fallon, Chief Executive Officer, David Heard, Chief Operating Officer, and Nancy Erba, Chief Financial Officer, are scheduled to participate at the Needham Virtual Security, Networking, and Communications Conference and present on Tuesday, November 17, 2020 at 11:00 a.m. Eastern Time.A live webcast, as well as the replay, of these presentations will be accessible from the Investors section of the Infinera’s website at investors.infinera.com and selecting events.Contacts:Media:Anna VueTel. +1 (916) 595-8157avue@infinera.comInvestors:Amitabh Passiapassi@infinera.comMichael Bowen, ICR, Inc.Tel. +1 (203) 682-8299Michael.Bowen@icrinc.comMarc P. Griffin, ICR, Inc.Tel. +1 (646)-277-1290Marc.Griffin@icrinc.comAbout InfineraInfinera...

Continue reading

Vaxcyte to Present at Jefferies Virtual London Healthcare Conference

FOSTER CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced that company management will present at the Jefferies Virtual London Healthcare Conference on Tuesday November 17, 2020 at 12:35pm ET.A live webcast of the presentation can be accessed through the Investors & Media section of the Company’s website at http://investors.vaxcyte.com. A replay of the webcast will be available for approximately 30 days following the conference.About VaxcyteVaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.